These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3580281)

  • 1. In-vitro teratogenicity of retinoids.
    Steele CE; Marlow R; Turton J; Hicks RM
    Br J Exp Pathol; 1987 Apr; 68(2):215-23. PubMed ID: 3580281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative teratogenicity of nine retinoids in the rat.
    Turton JA; Willars GB; Haselden JN; Ward SJ; Steele CE; Hicks RM
    Int J Exp Pathol; 1992 Oct; 73(5):551-63. PubMed ID: 1419774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of co-administration of retinoids on rat embryo development in vitro.
    Ritchie HE; Brown-Woodman PD; Korabelnikoff A
    Birth Defects Res A Clin Mol Teratol; 2003 Jun; 67(6):444-51. PubMed ID: 12962289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution, teratogenicity, and embryonic delivered dose of retinoid Ro 23-9223.
    Willhite CC; Lovey A; Eckhoff C
    Toxicol Appl Pharmacol; 2000 Apr; 164(2):171-5. PubMed ID: 10764630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplacental pharmacokinetics of teratogenic doses of etretinate and other aromatic retinoids in mice.
    Reiners J; Löfberg B; Kraft JC; Kochhar DM; Nau H
    Reprod Toxicol; 1988; 2(1):19-29. PubMed ID: 2980988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teratogenicity of arotinoids (retinoids) in the rat whole embryo culture.
    Bechter R; Terlouw GD; Tsuchiya M; Tsuchiya T; Kistler A
    Arch Toxicol; 1992; 66(3):193-7. PubMed ID: 1497483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Teratogenicity of the 13-cis and all-trans-isomers of the aromatic retinoid etretin: correlation to transplacental pharmacokinetics in mice during organogenesis after a single oral dose.
    Löfberg B; Chahoud I; Bochert G; Nau H
    Teratology; 1990 Jun; 41(6):707-16. PubMed ID: 2141193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative teratogenic activity of cancer chemopreventive retinoidal benzoic acid congeners (arotinoids).
    Flanagan JL; Willhite CC; Ferm VH
    J Natl Cancer Inst; 1987 Mar; 78(3):533-8. PubMed ID: 3469465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative teratogenic activities of two retinoids: effects on palate and limb development.
    Kochhar DM; Penner JD; Tellone CI
    Teratog Carcinog Mutagen; 1984; 4(4):377-87. PubMed ID: 6149630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative developmental toxicity potencies of retinoids in the embryonic stem cell test compared with their relative potencies in in vivo and two other in vitro assays for developmental toxicity.
    Louisse J; Gönen S; Rietjens IM; Verwei M
    Toxicol Lett; 2011 May; 203(1):1-8. PubMed ID: 21362465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor-selective retinoid agonists and teratogenic activity.
    Willhite CC; Dawson MI; Reichert U
    Drug Metab Rev; 1996; 28(1-2):105-19. PubMed ID: 8744592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biotransformation of etretinate and developmental toxicity of etretin and other aromatic retinoids in teratogenesis bioassays.
    Kochhar DM; Penner JD; Minutella LM
    Drug Metab Dispos; 1989; 17(6):618-24. PubMed ID: 2575497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microinjections of cultured rat conceptuses: studies with 4-oxo-all-trans-retinoic acid, 4-oxo-13-cis-retinoic acid and all-trans-retinoyl-beta-glucuronide.
    Kraft JC; Bechter R; Lee QP; Juchau MR
    Teratology; 1992 Mar; 45(3):259-70. PubMed ID: 1631780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low teratogenicity of 13-cis-retinoic acid (isotretinoin) in the mouse corresponds to low embryo concentrations during organogenesis: comparison to the all-trans isomer.
    Kraft JC; Kochhar DM; Scott WJ; Nau H
    Toxicol Appl Pharmacol; 1987 Mar; 87(3):474-82. PubMed ID: 3470977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limb bud cell cultures for estimating the teratogenic potential of compounds. Validation of the test system with retinoids.
    Kistler A
    Arch Toxicol; 1987 Aug; 60(6):403-14. PubMed ID: 2444191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Embryogenesis in cultured whole rat embryos after combined exposures to 3,3',5-triiodo-L-thyronine (T3) plus all-trans-retinoic acid and to T3 plus 9-cis-retinoic acid.
    Kraft JC; Willhite CC; Juchau MR
    J Craniofac Genet Dev Biol; 1994; 14(2):75-86. PubMed ID: 8071425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Teratogenicity of etretinate during early pregnancy in the rat and its correlation with maternal plasma concentrations of the drug.
    Agnish ND; Vane FM; Rusin G; DiNardo B; Dashman T
    Teratology; 1990 Jul; 42(1):25-33. PubMed ID: 2144063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative teratogenicity of three retinoids: the arotinoids Ro 13-7410, Ro 13-6298 and Ro 15-1570.
    Kistler A; Galli B; Howard WB
    Arch Toxicol; 1990; 64(1):43-8. PubMed ID: 2306193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinamides: hydrolytic conversion of retinoylglycine to retinoic acid in pregnant mice contributes to teratogenicity.
    Kochhar DM; Shealy YF; Penner JD; Jiang H
    Teratology; 1992 Feb; 45(2):175-85. PubMed ID: 1615427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of developmental toxicity and teratogenicity of cyclosporine A, tacrolimus and their combinations with prednisolone.
    Unver Dogan N; Uysal II; Fazliogullari Z; Karabulut AK; Acar H
    Regul Toxicol Pharmacol; 2016 Jun; 77():213-22. PubMed ID: 26993750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.